Vol 5, No 1 (January 13, 2017): Annals of Translational Medicine (Focus on “MET as Actionable Target in Cancer Therapy”)

Preface on MET as Actionable Target in Cancer Therapy1

Special issue: “MET as actionable target in cancer therapy”
Patrick C. Ma
Annals of Translational Medicine
 2017;
5
(1)
:1

Review Article on MET as Actionable Target in Cancer Therapy1

MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy
Sara Pilotto, Anastasios Gkountakos, Luisa Carbognin, Aldo Scarpa, Giampaolo Tortora, Emilio Bria
Annals of Translational Medicine
 2017;
5
(1)
:2
Effective implementation of novel MET pharmacodynamic assays in translational studies
Apurva K. Srivastava, Tony Navas, William G. Herrick, Melinda G. Hollingshead, Donald P. Bottaro, James H. Doroshow, Ralph E. Parchment
Annals of Translational Medicine
 2017;
5
(1)
:3
MET/HGF pathway activation as a paradigm of resistance to targeted therapies
Brian Ko, Tianfang He, Shirish Gadgeel, Balazs Halmos
Annals of Translational Medicine
 2017;
5
(1)
:4
MET: roles in epithelial-mesenchymal transition and cancer stemness
Hye-Min Jeon, Jeongwu Lee
Annals of Translational Medicine
 2017;
5
(1)
:5

Column in Laboratory Medicine2

Laboratory monitoring of direct oral anticoagulants (DOACs)—The perfect storm?
Giuseppe Lippi, Emmanuel J. Favaloro
Annals of Translational Medicine
 2017;
5
(1)
:6

Big-data Clinical Trial Column3

Propensity score method: a non-parametric technique to reduce model dependence
Zhongheng Zhang
Annals of Translational Medicine
 2017;
5
(1)
:7

Commentary

Has the time come to abandon chloride-rich resuscitation fluids?
Michael Heung, Lenar Yessayan
Annals of Translational Medicine
 2017;
5
(1)
:12
Another look at CHG bathing in a surgical intensive care unit
Kyle J. Popovich
Annals of Translational Medicine
 2017;
5
(1)
:13
Chlorhexidine gluconate use to prevent hospital acquired infections—a useful tool, not a panacea
Elizabeth Wenqian Wang, A. Joseph Layon
Annals of Translational Medicine
 2017;
5
(1)
:14
Sonographic evaluation of the diaphragm morphology and function in the critically ill
Kavi Haji, Alistair Royse
Annals of Translational Medicine
 2017;
5
(1)
:15
IL-6 and type 1 diabetes mellitus: T cell responses and increase in IL-6 receptor surface expression
Karina Braga Gomes
Annals of Translational Medicine
 2017;
5
(1)
:16
Automated early warning system for septic shock: the new way to achieve intensive care unit quality improvement?
Fábio Ferreira Amorim, Alfredo Nicodemos Cruz Santana
Annals of Translational Medicine
 2017;
5
(1)
:17
Nanodiamonds and nanoparticles as tumor cell radiosensitizers—promising results but an obscure mechanism of action
Martin Falk
Annals of Translational Medicine
 2017;
5
(1)
:18
Left ventricle-mitral valve ring size mismatch: understanding the limitations of mitral valve repair for ischemic mitral regurgitation
Christos G. Mihos, Evin Yucel, Orlando Santana
Annals of Translational Medicine
 2017;
5
(1)
:19
Contemporary issues in endoscopic resection for esophageal squamous cell cancer
Emmanuel Gabriel, Steven N. Hochwald
Annals of Translational Medicine
 2017;
5
(1)
:20
miR-21 alters circulating Treg function in vascular disease—hope for restoring immunoregulatory responses in atherosclerosis?
Emer E. Hackett, Frederick J. Sheedy
Annals of Translational Medicine
 2017;
5
(1)
:21
Vascular changes and perifascicular muscle fiber damage in dermatomyositis: another question of the chicken or the egg that is on our mind
Boel De Paepe
Annals of Translational Medicine
 2017;
5
(1)
:22
A novel role of exosomes in the vaccination approach
Pradip B. Devhare, Ratna B. Ray
Annals of Translational Medicine
 2017;
5
(1)
:23

Viewpoint

Exercising recommendations for paroxysmal AF in young and middle-aged athletes (PAFIYAMA) syndrome
Carme Perez-Quilis, Giuseppe Lippi, Gianfranco Cervellin, Herbert Löllgen, Fabian Sanchis-Gomar
Annals of Translational Medicine
 2017;
5
(1)
:24

Correspondence

Narcolepsy and influenza vaccination-induced autoimmunity
S. Sohail Ahmed, Lawrence Steinman
Annals of Translational Medicine
 2017;
5
(1)
:25

Disclosure:

1. The series “MET as Actionable Target in Cancer Therapy” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding. Patrick C. Ma served as the unpaid Guest Editor for the series.

2. The series “Column in Laboratory Medicine” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.

3. The series “Big-data Clinical Trial Column” was commissioned by the editorial office, Annals of Translational Medicine without any sponsorship or funding.